hbv |
25 |
chronic hepatitis b |
24 |
hepatocellular carcinoma |
24 |
hepatitis b virus |
23 |
medical sciences |
21 |
adult |
20 |
female |
20 |
humans |
20 |
male |
20 |
hbsag |
19 |
adolescent |
17 |
entecavir |
17 |
middle aged |
17 |
aged |
16 |
antiviral therapy |
16 |
gastroenterology |
16 |
hepatitis b |
15 |
hepatitis b surface antigen |
15 |
nafld |
15 |
functional cure |
14 |
liver fibrosis |
14 |
mutation |
14 |
aged, 80 and over |
13 |
dna, viral - blood |
13 |
flare |
13 |
follow-up studies |
13 |
hcv |
13 |
liver cancer |
13 |
liver stiffness |
13 |
antiviral |
12 |
chronic viral hepatitis |
12 |
dna, viral - analysis |
12 |
genotype |
12 |
hepatitis b virus - genetics |
12 |
nucleos(t)ide analogue |
12 |
nucleoside analogues |
12 |
risk factors |
12 |
virus replication |
12 |
age |
11 |
alanine aminotransferase |
11 |
cirrhosis |
11 |
controlled attenuation parameter |
11 |
extracellular vesicles |
11 |
fibrosis |
11 |
hepatitis b core-related antigen |
11 |
liver cirrhosis - complications - diagnosis |
11 |
longitudinal studies |
11 |
nidogen 1 |
11 |
predictive value of tests |
11 |
pre‐metastatic niche |
11 |
tumor necrosis factor receptor 1 |
11 |
alanine transaminase - blood |
10 |
biomarker |
10 |
carcinoma, hepatocellular - etiology |
10 |
carcinoma, hepatocellular - virology |
10 |
child |
10 |
child, preschool |
10 |
hepatitis b antibodies - blood |
10 |
hepatitis b e antigens - blood |
10 |
hong kong - epidemiology |
10 |
infant |
10 |
intercellular communication |
10 |
liver - pathology - virology |
10 |
liver cirrhosis - etiology |
10 |
liver neoplasms - virology |
10 |
m2bpgi |
10 |
models, biological |
10 |
neutralizing antibody |
10 |
proteomics |
10 |
surface antigen |
10 |
tumor microenvironment |
10 |
vaccination |
10 |
antiviral agents - therapeutic use |
9 |
asian continental ancestry group - statistics & numerical data |
9 |
carrier state |
9 |
fatty liver disease |
9 |
hav |
9 |
hbeag |
9 |
hepatitis b surface antigens - immunology |
9 |
hepatitis b virus - genetics - immunology - isolation & purification |
9 |
hepatitis b, chronic - pathology |
9 |
hev |
9 |
immigration |
9 |
liver cirrhosis - pathology - virology |
9 |
liver neoplasms - etiology |
9 |
nash |
9 |
non-viral liver disease |
9 |
pre-s deletions |
9 |
prognosis |
9 |
reproducibility of results |
9 |
seroclearance |
9 |
tenofovir |
9 |
tumorigenesis |
9 |
alanine transaminase - metabolism |
8 |
cccdna |
8 |
elasticity imaging techniques |
8 |
elasticity imaging techniques - methods |
8 |
galectin-1 |
8 |
hbcrag |
8 |
hbv dna |
8 |
hepatitis b e antigens - metabolism |
8 |
hepatitis b virus - genetics - immunology |
8 |
hepatitis b, chronic - complications - diagnosis |
8 |
hepatitis b, chronic - drug therapy - virology |
8 |
hla‐dp |
8 |
ifn‐γ pathway |
8 |
immune response |
8 |
lamivudine - therapeutic use |
8 |
liver failure - pathology - virology |
8 |
mir-22 |
8 |
mortality |
8 |
nephrotoxicity |
8 |
otx008 |
8 |
protein precursors - genetics |
8 |
reverse transcriptase inhibitors - therapeutic use |
8 |
serology |
8 |
therapeutics |
8 |
accuracy |
7 |
alanine aminotransferase blood level |
7 |
cap |
7 |
diagnostic test accuracy study |
7 |
disease progression |
7 |
disease severity |
7 |
drug response |
7 |
elastography |
7 |
endocrinology |
7 |
etv |
7 |
hepatitis b core antigens - genetics |
7 |
hepatitis b virus - classification - genetics |
7 |
hepatitis b virus - drug effects - genetics |
7 |
hepatitis b virus - physiology |
7 |
hepatitis b virus infection |
7 |
hepatitis b, chronic - blood - drug therapy - virology |
7 |
hepatitis b, chronic - complications |
7 |
hepatitis b, chronic - enzymology - pathology |
7 |
hepatitis c |
7 |
itraq |
7 |
liver - chemistry - pathology |
7 |
liver - pathology |
7 |
liver cirrhosis - enzymology - pathology |
7 |
metabolic |
7 |
metabolic syndrome |
7 |
mutation - genetics |
7 |
natural history |
7 |
nucleoside analogue |
7 |
obesity |
7 |
promoter regions, genetic |
7 |
risk factor |
7 |
transient elastography |
7 |
treatment outcome |
7 |
viral load |
7 |
young adult |
7 |
adefovir |
6 |
age factors |
6 |
anti-hbc |
6 |
anti-hbs |
6 |
antibody to hepatitis b surface antigen |
6 |
blood donors - statistics and numerical data |
6 |
carcinoma, hepatocellular - diagnosis - epidemiology |
6 |
carcinoma, hepatocellular - ethnology - pathology - virology |
6 |
carrier state - epidemiology - pathology |
6 |
chronic hepatitis b virus |
6 |
cigarette smoking |
6 |
circular dna |
6 |
covalently closed circular dna |
6 |
dna methylation |
6 |
drug resistance, viral |
6 |
drug therapy, combination |
6 |
enhancer elements (genetics) - genetics |
6 |
epidemiology |
6 |
fatty liver |
6 |
fibroscan |
6 |
full-length genome sequencing |
6 |
gastric cancer |
6 |
genotype 1 |
6 |
genotype 6 |
6 |
gitr |
6 |
guanine - analogs and derivatives - therapeutic use |
6 |
hbeag seroconversion |
6 |
hcc |
6 |
hepacivirus - classification - genetics - pathogenicity |
6 |
hepatitis b core‐related antigen |
6 |
hepatitis b serum markers |
6 |
hepatitis b surface antigens - blood - immunology |
6 |
hepatitis b virus - drug effects |
6 |
hepatitis b(e) antigen |
6 |
hepatitis b, chronic - blood - complications - genetics |
6 |
hepatitis b, chronic - blood - complications - immunology - pathology - virology |
6 |
hepatitis b, chronic - complications - drug therapy |
6 |
hepatitis b, chronic - drug therapy - enzymology - immunology |
6 |
hepatitis b, chronic - epidemiology - pathology |
6 |
hepatitis b, chronic - ethnology - immunology - pathology |
6 |
hepatitis c, chronic - complications - metabolism - virology |
6 |
host-pathogen interactions |
6 |
hs-hbsag |
6 |
immune exhaustion |
6 |
inflammation |
6 |
interleukin‐27 |
6 |
intrahepatic hbv dna |
6 |
kinetics |
6 |
lamivudine |
6 |
lamivudine - adverse effects - therapeutic use |
6 |
lamivudine - pharmacology - therapeutic use |
6 |
liver biopsy |
6 |
liver cirrhosis - ethnology - pathology - virology |
6 |
liver neoplasms - diagnosis - epidemiology |
6 |
liver neoplasms - ethnology - pathology - virology |
6 |
longitudinal |
6 |
mac-2 binding protein glycosylation isomer |
6 |
mass screening - methods |
6 |
na therapy |
6 |
non-alcoholic fatty liver disease |
6 |
pd-1 |
6 |
prediction |
6 |
prevalence |
6 |
promoter regions (genetics) - genetics |
6 |
promoter regions, genetic - genetics |
6 |
proportional hazards models |
6 |
prospective studies |
6 |
quasispecies |
6 |
regulatory t cells |
6 |
response to therapy |
6 |
seroepidemiologic studies |
6 |
sex factors |
6 |
spontaneous hbeag seroconversion |
6 |
t regulatory cells |
6 |
tenofovir hbsag surface antigen nucleoside analogue nucleotide analogue tdf |
6 |
time factors |
6 |
vcte |
6 |
viral core proteins - genetics |
6 |
viral hepatitis |
6 |
virus dna |
6 |
wfa + -m2bp |
6 |
alanine transaminase - analysis |
5 |
alkaline phosphatase - blood |
5 |
alpha-fetoproteins - analysis |
5 |
anaemia |
5 |
antiviral agents - administration and dosage - therapeutic use |
5 |
antiviral agents - adverse effects - therapeutic use |
5 |
asian continental ancestry group |
5 |
aspartate aminotransferases - blood |
5 |
bilirubin - blood |
5 |
carcinoma, hepatocellular - diagnosis - pathology |
5 |
carcinoma, hepatocellular - epidemiology - genetics - virology |
5 |
case-control studies |
5 |
china |
5 |
core antigen |
5 |
core protein |
5 |
core protein allosteric modulator |
5 |
cure |
5 |
customized therapies |
5 |
deep sequencing |
5 |
deleterious mutations |
5 |
dna, circular - analysis - isolation & purification |
5 |
dna, viral - analysis - isolation & purification |
5 |
dna, viral - genetics |
5 |
dna-directed dna polymerase - genetics |
5 |
drugs, chinese herbal - adverse effects |
5 |
dyslipidemia |
5 |
fibrosis regression |
5 |
finite |
5 |
freezing |
5 |
gamma-glutamyltransferase - blood |
5 |
gene deletion |
5 |
gene expression regulation, viral |
5 |
gene silencing |
5 |
genetic predisposition to disease |
5 |
globulins - analysis |
5 |
guanine - administration and dosage - analogs and derivatives - therapeutic use |
5 |
hbx |
5 |
hbx protein |
5 |
hepacivirus - genetics |
5 |
hepatitic decompensation |
5 |
hepatitis b - drug therapy - genetics - physiopathology - virology |
5 |
hepatitis b core antigens - genetics - immunology |
5 |
hepatitis b e antigen seroconversion |
5 |
hepatitis b e antigens - biosynthesis - genetics - immunology |
5 |
hepatitis b surface antigens - blood |
5 |
hepatitis b surface antigens - blood - chemistry |
5 |
hepatitis b surface antigens - genetics |
5 |
hepatitis b surface antigens - metabolism |
5 |
hepatitis b virus - chemistry - classification - genetics |
5 |
hepatitis b virus - drug effects - enzymology - genetics |
5 |
hepatitis b virus - genetics - immunology - isolation and purification |
5 |
hepatitis b virus - genetics - isolation and purification |
5 |
hepatitis b virus dna rebound |
5 |
hepatitis b virus replication |
5 |
hepatitis b, chronic - blood - drug therapy |
5 |
hepatitis b, chronic - blood - pathology - virology |
5 |
hepatitis b, chronic - complications - genetics - virology |
5 |
hepatitis b, chronic - complications - mortality - pathology |
5 |
hepatitis b, chronic - complications - virology |
5 |
hepatitis b, chronic - drug therapy |
5 |
hepatitis b, chronic - epidemiology - physiopathology - virology |
5 |
hepatitis b, chronic - genetics - immunology - virology |
5 |
hepatitis c virus |
5 |
hepatitis c, chronic - drug therapy - virology |
5 |
herbal medicine |
5 |
interferon-alpha - therapeutic use |
5 |
interferon-gamma - biosynthesis - immunology |
5 |
interleukin-10 - immunology |
5 |
interleukin-2 - immunology |
5 |
interleukin-4 - immunology |
5 |
interleukin-5 - immunology |
5 |
intrahepatic hepatitis b virus dna |
5 |
lamivudine - administration & dosage - therapeutic use |
5 |
linearized hbsag |
5 |
liver |
5 |
liver - metabolism |
5 |
liver - virology |
5 |
liver biochemistry |
5 |
liver cirrhosis |
5 |
liver cirrhosis - diagnosis |
5 |
liver diseases - etiology |
5 |
liver histology |
5 |
liver neoplasms - epidemiology - genetics - virology |
5 |
liver steatosis |
5 |
liver transplantation |
5 |
lymphocyte activation |
5 |
medical sciences - oncology |
5 |
medical sciences - urology and nephrology |
5 |
medicine, chinese traditional - adverse effects |
5 |
microrna |
5 |
multivariate analysis |
5 |
nucleocapsid |
5 |
nucleosides - pharmacology - therapeutic use |
5 |
nucleotide analogue |
5 |
obese mice |
5 |
occult hepatitis b infection |
5 |
polyethylene glycols - therapeutic use |
5 |
polymorphism, genetic |
5 |
precore mutation |
5 |
promoter regions (genetics) |
5 |
protein stability |
5 |
pyrimidinones - pharmacology - therapeutic use |
5 |
quantitative |
5 |
recombinant proteins |
5 |
resistance |
5 |
reverse transcriptase inhibitors - administration & dosage - therapeutic use |
5 |
reverse transcriptase polymerase chain reaction |
5 |
ribavirin |
5 |
ribavirin - therapeutic use |
5 |
rna, messenger - analysis - isolation & purification |
5 |
rna, viral - analysis - isolation & purification |
5 |
roc curve |
5 |
serologic tests |
5 |
severe hepatitis b exacerbation |
5 |
single polynucleotide polymorphisms |
5 |
sirt1 |
5 |
sirtuin |
5 |
specimen handling - methods |
5 |
statistics, nonparametric |
5 |
stopping |
5 |
survival analysis |
5 |
sustained virologic response |
5 |
t helper response |
5 |
targeted sequencing |
5 |
th1 cells - immunology |
5 |
th2 cells - immunology |
5 |
transcription |
5 |
translation |
5 |
treatment guidelines |
5 |
tumor |
5 |
viraemia |
5 |
viral suppression |
5 |
virology |
5 |
week 12 |
5 |
week 24 |
5 |
ymdd mutation |
5 |
actins - genetics |
4 |
adenine - analogs & derivatives - therapeutic use |
4 |
age distribution |
4 |
amino acid motifs - drug effects - genetics |
4 |
anti-hepatitis b core total antibodies |
4 |
anti-hiv agents - therapeutic use |
4 |
antineoplastic agents - administration & dosage |
4 |
antiviral agents - pharmacology - therapeutic use |
4 |
apoptosis |
4 |
asian continental ancestry group - ethnology |
4 |
asian continental ancestry group - genetics |
4 |
aspartic acid - drug effects - genetics |
4 |
bacteroides |
4 |
bile acid |
4 |
biological markers - blood |
4 |
biopsy - methods |
4 |
blood - virology |
4 |
blood transfusion - adverse effects |
4 |
carcinoma, hepatocellular - diagnosis - virology |
4 |
carcinoma, hepatocellular - mortality - pathology - therapy |
4 |
care cascade |
4 |
chemoembolization, therapeutic - methods |
4 |
china - ethnology |
4 |
cisplatin - administration & dosage |
4 |
cohort studies |
4 |
contrast media - administration & dosage |
4 |
core promoter mutation |
4 |
core-promoter mutation |
4 |
cross-sectional studies |
4 |
cytokines |
4 |
dna methylation - immunology |
4 |
dna, circular - analysis |
4 |
dna, circular - blood - drug effects |
4 |
dna, viral - blood - drug effects |
4 |
dna, viral - blood - isolation & purification |
4 |
dna, viral - genetics - isolation and purification |
4 |
dose-response relationship, immunologic |
4 |
drug resistance, multiple, viral - genetics |
4 |
drug resistance, viral - genetics |
4 |
e-cadherin |
4 |
elasticity |
4 |
enzyme-linked immunosorbent assay - methods |
4 |
estrogen |
4 |
gastritis/genetics - immunology/prevention & control |
4 |
gender difference |
4 |
gene products, pol - genetics |
4 |
guanine - analogs & derivatives - therapeutic use |
4 |
harm reduction |
4 |
hbsag level |
4 |
hbv infection |
4 |
hbv transcription |
4 |
helicobacter infections/genetics - immunology/microbiology |
4 |
helicobacter pylori |
4 |
hepatic artery |
4 |
hepatitis |
4 |
hepatitis b - complications |
4 |
hepatitis b - drug therapy - genetics |
4 |
hepatitis b - drug therapy - virology |
4 |
hepatitis b - immunology - prevention & control |
4 |
hepatitis b - pathology |
4 |
hepatitis b - transmission |
4 |
hepatitis b - virology |
4 |
hepatitis b antibodies - blood - immunology |
4 |
hepatitis b core antigen |
4 |
hepatitis b core antigens - blood |
4 |
hepatitis b core antigens - metabolism |
4 |
hepatitis b core protein |
4 |
hepatitis b genotype |
4 |
hepatitis b vaccines - administration & dosage - immunology |
4 |
hepatitis b virus - chemistry |
4 |
hepatitis b virus - classification - genetics - isolation & purification - pathogenicity |
4 |
hepatitis b virus - classification - genetics - isolation and purification |
4 |
hepatitis b virus - genetics - isolation & purification |
4 |
hepatitis b, chronic - blood - drug therapy - genetics |
4 |
hepatitis b, chronic - blood - drug therapy - immunology |
4 |
hepatitis b, chronic - classification - diagnosis |
4 |
hepatitis b, chronic - complications - drug therapy - ethnology |
4 |
hepatitis b, chronic - complications - ethnology - therapy |
4 |
hepatitis b, chronic - diagnosis |
4 |
hepatitis b, chronic - drug therapy - ethnology - pathology |
4 |
hepatitis b, chronic - genetics - metabolism - pathology |
4 |
hepatitis b, chronic - metabolism |
4 |
hepatitis b, chronic - pathology - physiopathology |
4 |
hepatitis b, chronic - physiopathology - virology |
4 |
histology |
4 |
histone acetylation |
4 |
hong kong |
4 |
hq-hbsag |
4 |
immunization schedule |
4 |
immunization, secondary |
4 |
immunogenicity |
4 |
immunohistochemistry |
4 |
immunologic memory |
4 |
injections, intra-arterial - methods |
4 |
interleukin-1 receptor type 1 knockout mice |
4 |
interleukin-1b |
4 |
interleukin-1beta/genetics - immunology/metabolism |
4 |
interleukin-1β |
4 |
iodized oil - administration & dosage |
4 |
ip-10 |
4 |
isoleucine - genetics |
4 |
lamivudine - administration & dosage |
4 |
linkage to care |
4 |
liver cirrhosis - diagnosis - epidemiology - virology |
4 |
liver cirrhosis - pathology |
4 |
liver cirrhosis - pathology - physiopathology |
4 |
liver cirrhosis - physiopathology - virology |
4 |
liver cirrhosis - virology |
4 |
liver function tests |
4 |
liver neoplasms - diagnosis - virology |
4 |
liver neoplasms - mortality - pathology - therapy |
4 |
luminescent measurements - methods |
4 |
methionine - drug effects - genetics |
4 |
microbiota |
4 |
mutation, missense - genetics |
4 |
necroinflammation |
4 |
necrosis - pathology |
4 |
neoplasm staging |
4 |
nitric oxide |
4 |
phosphonic acids - therapeutic use |
4 |
placebos |
4 |
point of care test |
4 |
pwid |
4 |
receptors, interleukin-1 type i/genetics - immunology/metabolism |
4 |
retrospective studies |
4 |
reverse transcriptase inhibitors - administration & dosage |
4 |
rna-directed dna polymerase - genetics |
4 |
sex distribution |
4 |
statistics as topic |
4 |
survival rate |
4 |
tyrosine - drug effects - genetics |
4 |
vaccines, dna - administration & dosage - immunology |
4 |
valine - genetics |
4 |
viremia - complications |
4 |
automation - instrumentation - methods |
3 |
bacteriophage m13 - genetics |
3 |
complications |
3 |
core promoter mutations |
3 |
dna primers |
3 |
eurohep reference plasma |
3 |
hbeag seroreversion |
3 |
hbv dna assays |
3 |
hbv-dna |
3 |
hepatitis b - blood - diagnosis |
3 |
hepatitis b - prevention & control |
3 |
hepatitis b core antigens - immunology |
3 |
hepatitis b e antigens - genetics |
3 |
hepatitis b vaccines - administration & dosage |
3 |
hepatitis b virus - drug effects - isolation & purification |
3 |
hepatitis b virus - genetics - isolation & purification - pathogenicity |
3 |
hepatitis b virus - genetics - isolation & purification - physiology |
3 |
hepatitis b, chronic - blood - complications |
3 |
hepatitis b, chronic - blood - diagnosis |
3 |
hepatitis b, chronic - epidemiology - immunology - virology |
3 |
hepatitis b, chronic - virology |
3 |
hepatocarcinogenesis |
3 |
jnj-3989 |
3 |
liver cirrhosis - blood - complications - virology |
3 |
occult hepatitis b |
3 |
pathogenesis |
3 |
polymerase chain reaction - methods |
3 |
precore mutations |
3 |
reagent kits, diagnostic |
3 |
rna interference |
3 |
sensitivity and specificity |
3 |
serum albumin |
3 |
angiography |
2 |
bare metal stent |
2 |
carcinogenesis |
2 |
colorectal malignant neoplasm |
2 |
estrogen receptor α |
2 |
in-stent restenosis |
2 |
methylation |
2 |
mir-130a |
2 |
neoplasm |
2 |
nonalcoholic fatty liver disease |
2 |
amino acid sequence |
1 |
animals |
1 |
bacterial adhesion |
1 |
bacterial proteins |
1 |
bacterial proteins - genetics |
1 |
bacterial proteins - genetics - metabolism |
1 |
bacterial proteins - genetics - physiology |
1 |
base sequence |
1 |
cell fractionation |
1 |
cell line |
1 |
cells, cultured |
1 |
culture media |
1 |
dna, bacterial - metabolism |
1 |
dna, superhelical - chemistry |
1 |
dna-binding proteins - genetics - metabolism |
1 |
electrophoresis, polyacrylamide gel |
1 |
enzyme-linked immunosorbent assay |
1 |
epithelial cells - microbiology |
1 |
fimbriae proteins |
1 |
fimbriae, bacterial - genetics - ultrastructure |
1 |
fimbriae, bacterial - physiology |
1 |
genes, bacterial |
1 |
hegf |
1 |
hexosyltransferases - analysis - chemistry - genetics |
1 |
immunoblotting |
1 |
intestinal mucosa - microbiology |
1 |
lac operon |
1 |
light-harvesting protein complexes |
1 |
lipopolysaccharide |
1 |
membrane proteins - genetics |
1 |
mice |
1 |
mice, inbred balb c |
1 |
molecular sequence data |
1 |
mutagenesis, insertional |
1 |
mutagenesis, site-directed |
1 |
open reading frames |
1 |
operon |
1 |
peptides - analysis |
1 |
photosynthesis - genetics |
1 |
photosynthetic reaction center complex proteins - genetics |
1 |
plasmid pslt |
1 |
plasmids |
1 |
protein biosynthesis |
1 |
recombinant fusion proteins - analysis - chemistry - isolation & purification |
1 |
rfc |
1 |
rhodobacter capsulatus - genetics - growth & development - metabolism |
1 |
salmonella typhi - genetics - pathogenicity |
1 |
salmonella typhimurium - enzymology - genetics - growth & development |
1 |
salmonella typhimurium - genetics |
1 |
semi-rough |
1 |
sequence homology, amino acid |
1 |
serotyping |
1 |
transcription factors - genetics |
1 |
transcription, genetic |
1 |
typhoid fever - etiology |
1 |
virulence - genetics |
1 |
wzy |
1 |
ytl2-incr stabilization |
1 |